QualityStocks Stock Newsletters Archives - Page 382 of 1818

WednesdayOct 20, 2010 1:12 pm

Finding a Cure for Breast Cancer

As you probably already know by now, October is National Breast Cancer Awareness Month. A leading type of cancer among women, only second to lung cancer, much research is being done to discover a cure. It has been estimated that 25 deaths due to breast cancer occur each year for every 100,000 women in the United States. As a result of continued progress with cancer research, the breast cancer death rate has steadily decreased but no "magic bullet" currently exists. This year we’re supporting the cause through a donation to the National Breast Cancer Foundation (www.nationalbreastcancer.org). This organization not only…

WednesdayOct 20, 2010 12:21 pm

BPZ Resources, Inc. (BPZ) Video Chart for Wednesday, October 20, 2010

BPZ is once again holding support and making a nice, rounded bottom. We are watching for volume to stay strong as the indicators continue to trend to positions that indicate a possible move. Please click the following link: http://www.qualitystocks.net/videocharts.php Let us hear your thoughts below:

WednesdayOct 20, 2010 12:06 pm

Titan Energy Worldwide, Inc. (TEWI.OB) Completes Stanza Systems Acquisition

Titan Energy Worldwide, a leader in distributed power generation products and intelligent energy management services, today announced the closing of its acquisition of Stanza Systems. Stanza is a leading network communications and Smart Grid development company based in Houston, Texas. Among other things, Stanza develops advanced network technologies for various Fortune 500 companies, and is known for key innovations in the operation of large scale wireless networks. The acquisition gives Titan a platform for the development and management of its remote monitoring and automated control systems for onsite power generation. Titan Chairman and CEO, Jeffrey Flannery, said of the closing,…

WednesdayOct 20, 2010 12:05 pm

Voyager Oil & Gas, Inc. (VYOG.OB) Issues Oil and Gas Operational Update

Voyager Oil & Gas, Inc. issued an operational update on the company’s oil and gas exploration and development activities in the Western United States. The company is active in several different areas including the Williston and Denver Julesburg basins. Voyager Oil & Gas, Inc. has 24,000 net acres under lease in the Williston Basin, spread between North Dakota and Montana. The company has twelve gross wells in various stages of the drilling and completion process, and plans to spud three more wells before the end of 2010. Voyager Oil & Gas, Inc. plans to spud thirty-five gross, or five net…

WednesdayOct 20, 2010 9:12 am

Delisted! Generex Biotechnology Corp. (GNBT) Moving to Bulletin Boards; Files an Appeal

Generex Biotechnology received notice yesterday from the NASDAQ Listing Qualifications Panel that it has been determined to delist the Company’s common stock from the NASDAQ Capital Market and trading of the stock will be suspended as of the open on Thursday, October 21, 2010 as a result of non-compliance with the minimum $1.00 per share closing bid price requirement for continued listing on the NASDAQ CM. Generex will retain its ticker symbol of GNBT and begin trading and listing on the OTCBB through the OTCQB tier of Pink OTC Markets, Inc. Real time stock quotes for GNBT will be available…

WednesdayOct 20, 2010 9:04 am

Jacada Ltd. (ICDA) and Blue Cross Blue Shield of Massachusetts Join Forces

Located in various locations throughout the world, Jacada was founded in 1990 as a leading global provider of customer experience management and interaction solutions. Recently, Jacada took a major step towards prominence by signing an agreement with Blue Cross Blue Shield of Massachusetts (BCBSMA). BCBSMA was founded 73 years ago by a group of community-minded business leaders and has always followed the tradition set forth by these pioneers. With their headquarters in Boston, Mass, BCBSMA provides health coverage for nearly 3 million members. With the company having such an impact on their community, BCBSMA signed an agreement with Jacada to…

WednesdayOct 20, 2010 8:39 am

Intelligence Expert Joins PASSUR Aerospace, Inc. (PSSR.OB)

PASSUR Aerospace, Inc. announced yesterday that Mr. Richard L. Haver has joined its Board of Directors. Mr. Haver will soon retire as Vice President for Intelligence Programs, Northrop Grumman Corporation. Before joining Northrop Grumman, he was the Assistant Secretary of Defense for Intelligence. "PASSUR is the same kind of innovative information systems organization I have been associated with during my career in the intelligence field. They see a need, take a unique approach to addressing it, then produce results that profoundly change the game," said Rich Haver. "PASSUR's team of employees and directors, their extraordinary relationship with their customers, and…

WednesdayOct 20, 2010 8:37 am

Lotus Pharmaceuticals, Inc. (LTUS.OB) Subsidiary Receives Patent for Controlled-Release Diabetes Treatment

Yesterday, profitable medicine and drug manufacturer Lotus Pharmaceuticals, Inc., announced that the State Intellectual Property Office of the People’s Republic of China issued a patent to its wholly owned subsidiary, En Ze Jia Shi Pharmaceuticals. The patent, issued for controlled-release oral gliclazide, covers the composition and preparation methods for the drug through 2030. Gliclazide is commonly used to control mild to moderate adult-onset Type 2 diabetes. Lotus' innovative controlled-release tablet is formulated using osmotic pump technology, encasing the drug in a semi-permeable framework for a gradual, sustained release. As per the design, pH, gastric acid and food intake will have…

TuesdayOct 19, 2010 3:45 pm

MultiCell Technologies, Inc. (MCET.OB) Subsidiary Inks Worldwide Licensing for Medical Devices Intellectual Property

MultiCell Technologies Inc. and its majority owned subsidiary Xenogenics Corp. today jointly announced Xenogenics’ acquisition of Ideal™ BioStent, as well as Xenogenics’ worldwide exclusive license deal with Rutgers University for rights to certain intellectual property related to the Ideal BioStent. Analysts forecast the multi-billion dollar interventional cardiology and intravascular stent market to reach $4.6 billion at a growth rate of 3 percent to 4 percent annually. Advances in the market center on medical devices innovation that address long-term safety concerns, including the improvement of blood vessel health. The Ideal BioStent's is a layered technology that integrates different combinations of polymers…

TuesdayOct 19, 2010 1:37 pm

Astec Industries, Inc. (ASTE) Reports Third Quarter of 2010 Financial Results

Astec Industries, Inc. reported year over year increases in sales and net income in the third quarter of 2010. The company also reported a backlog of $145.6 million at the end of the quarter, up one percent from last year’s third quarter. Astec Industries, Inc. reported sales of $177.9 million in the quarter ending 9/30/2010, compared to sales of $166.1 million in the corresponding quarter of 2009. Domestic sales fell slightly on a year over basis to $98.6 million in the quarter that just ended, from $101.3 million in the third quarter of 2009. Astec Industries, Inc. saw a large…

Site Search

Company Search

Category: QualityStocks Stock Newsletters